Exicure gets Nasdaq extension as Exicure stock faces equity test
Published on 10/01/2026 at 15:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Exicure stock was last at USD 1.19 on Nasdaq on September 30, 2026, versus a USD 1.14 prior close. According to GlobeNewswire on September 16, 2026, Exicure received additional time to address a Nasdaq stockholders' equity requirement.
December deadline sets the test
The company must complete its compliance initiatives and publicly demonstrate at least USD 2.50 million in stockholders' equity by December 2, 2026. The requirement comes under Nasdaq Listing Rule 5550(b)(1), and Nasdaq will monitor the process through Exicure's next periodic report, according to GlobeNewswire.
The extension gives Exicure a defined compliance window, but it does not itself restore the listing standard. If the company fails to satisfy the terms, Nasdaq may issue a written delisting determination, with an appeal available before a Nasdaq Hearings Panel, the September 16 release said.
Small equity base meets Nasdaq rule
The equity threshold is material relative to Exicure's market value. The company had a market capitalization of USD 7.6 million as of September 30, 2026, while the Nasdaq requirement stood at USD 2.50 million.
Exicure's Nasdaq quotation also showed a 52-week range of USD 1.05 to USD 9.48 as of September 30, 2026. The USD 1.19 last price therefore sat USD 0.14 above the yearly low and USD 8.29 below the yearly high, keeping the listing deadline central to the stock's near-term risk profile.
Nasdaq price and market context
Exicure was last at USD 1.19 on Nasdaq on September 30, 2026 at 4:00 p.m. ET, compared with USD 1.14 at the prior close, a gain of 4.39 percent. Trading volume was 19,785 shares, and the market capitalization was USD 7.6 million.
Exicure stock facts
- Company: Exicure, Inc.
- Ticker: XCUR
- Primary exchange: Nasdaq
- Primary-exchange price: USD 1.19, last at September 30, 2026, 4:00 p.m. ET
- Change versus prior close: plus 4.39 percent
- Prior close: USD 1.14 on September 29, 2026
- Market capitalization: USD 7.6 million as of September 30, 2026
- 52-week range: USD 1.05-USD 9.48 as of September 30, 2026
- Sector / Industry: Healthcare / Biotechnology
